Trials / Completed
CompletedNCT06120777
Clinical Validation for SpO2 Function of Masimo INVSENSOR00069
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 89 (actual)
- Sponsor
- Masimo Corporation · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Assess the accuracy of INVSENSOR00069's peripheral oxygen saturation (SpO2) against contemporaneous measurement from arterial blood gas (ABG) analysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | INVSENSOR00069 | Noninvasive pulse oximeter |
Timeline
- Start date
- 2023-11-01
- Primary completion
- 2023-12-12
- Completion
- 2023-12-12
- First posted
- 2023-11-07
- Last updated
- 2024-11-27
- Results posted
- 2024-11-27
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06120777. Inclusion in this directory is not an endorsement.